Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OMS302 in Intraocular Lens Replacement
NCT01454063Phase 3Completed
- Sponsor
- Omeros Corporation
- Start
- Sep 2011
- Primary completion
- Mar 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of phenylephrine + ketorolac in cataract, sponsored by Omeros Corporation. Started Sep 2011; status: completed.
02
Drugs
phenylephrine + ketorolac
03
Conditions
cataract
Beyond the preview
Go deeper on NCT01454063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01454063.